Investor Hub

Novavax is a global biotechnology company focused on developing our R&D assets and establishing partnerships to maximize the impact of our cutting-edge technology in protecting health.

Latest quarterly earnings
Download PDF
Latest investor presentation
Download PDF
Annual report
Download PDF
Latest publications
See our research
Pipeline
View our pipeline
NASDAQ:NVAX
Loading data...
Stock details
NASDAQ:NVAX
Loading data...
Stock details
Latest quarterly earnings
Download PDF
Latest investor presentation
Download PDF
Annual report
Download PDF
Latest publications
See our research
Pipeline
View our pipeline
Latest press releasesEvents & presentationsReports & financialsSEC filingsStock details & analyst coverage
Press releases & statements
Aug 6, 2026
Press release
Corporate and finance

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Read full article
Download
Jul 30, 2026
Corporate and finance

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Read full article
Download
View all press releases
Latest press releases
Press releases & statements
Aug 6, 2026
Press release
Corporate and finance

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Read full article
Download
Jul 30, 2026
Corporate and finance

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Read full article
Download
View all press releases
Events & presentationsReports & financialsSEC filingsStock details & analyst coverage

Corporate governance

IR
contact

Phone
(844) 668-2829
Email
[email protected]

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings and more.

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.

Sign up for investor updates